Transcriptome Analysis of Ivosidenib-Mediated Inhibitory Functions on Non-Small Cell Lung Cancer

Ivosidenib is an isocitrate dehydrogenase mutant inhibitor that the US Food and Drug Administration recently approved for the treatment of leukemia. Studies suggested that ivosidenib may inhibit the progression of non-small cell lung cancer (NSCLC). In the present study, we explored RNAs and their p...

Descripción completa

Detalles Bibliográficos
Autores principales: Wu, Juan, Chen, Ru, Shen, Huiqing, Yan, Ting, Qian, Yu, Zhang, Yaping, Huang, Zhuoya, Kong, Pengzhou, Pang, Min, Zhang, Xinri
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8042334/
https://www.ncbi.nlm.nih.gov/pubmed/33859940
http://dx.doi.org/10.3389/fonc.2021.626605

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8042334/
https://www.ncbi.nlm.nih.gov/pubmed/33859940
http://dx.doi.org/10.3389/fonc.2021.626605

Ejemplares similares